{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Veliparib (ABT-888)",
        "type": {
          "id": "822dcffc-8a6a-4e47-a83f-a3e14851c509",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "a266cfab-86c7-4876-8960-b1b8fcc7e1b9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "a82c5f12-0874-4428-b126-d98e324c6759",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "d4a30072-6c32-4766-8e3a-da19f6693de1",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for veliparib.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Carboplatin",
        "type": {
          "id": "c923c9ec-a493-412f-a2c6-20c4c203f8ec",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "eca38b28-25e6-4c7a-8ae3-96b15e2876a8",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Paclitaxel",
        "type": {
          "id": "1400f55c-bd50-4f43-834d-e03b45863940",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "24d12e5b-a1c8-4383-89fb-1cd9f887bd1b",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Cytotoxic chemotherapy administered as reference therapy.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "82e0f3e2-c514-41b4-8923-19b2a94428b0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9e00fd60-4b9d-4003-be46-9d8ee809f132",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions.",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "Diphenhydramine",
        "type": {
          "id": "9b391a42-0918-4797-8a59-fc1aee498e6e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "c98b872d-fdf7-45e1-8979-4707f56e3a48",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_7",
        "name": "H2 antagonists",
        "type": {
          "id": "6a4a3a7f-e0dc-4ebd-827e-1f76c97a68e0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "284b95be-e90e-4c7b-abee-eeea19df8845",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "id": "int_8",
        "name": "Palonosetron",
        "type": {
          "id": "7ed78f54-6014-4bfc-83e8-21d612837c83",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "c6f87bdd-ce38-48c4-b27e-35149e5c3988",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_9",
        "name": "Dexamethasone",
        "type": {
          "id": "c22709d9-d6c5-44b1-880c-dad2dd8f969a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8de54396-20b8-4750-ada5-169e78d8b809",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "id": "int_10",
        "name": "Aprepitant",
        "type": {
          "id": "55f140d1-8bff-47a1-97c7-218eeac39fe4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "64fc1d9f-c653-4fea-8d23-682693659481",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Optional antiemetic."
      },
      {
        "id": "int_11",
        "name": "G-CSF",
        "type": {
          "id": "99206fba-ebb6-4d04-8fe3-440aaa454ae8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0b8696ae-34d7-47d7-a081-29d83673a580",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "id": "int_12",
        "name": "Bisphosphonates",
        "type": {
          "id": "48e7154c-3b70-4971-bbbd-e42a18355f93",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9c26b444-d776-46fd-a256-865854afd2f5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "id": "int_13",
        "name": "Denosumab",
        "type": {
          "id": "25780fac-57d7-44dd-90da-7bf282769629",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "a93faa79-c0d0-4f12-a878-5a1044016078",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for management of bone metastases."
      },
      {
        "id": "int_14",
        "name": "Anticancer hormonal therapy",
        "type": {
          "id": "7780a2a5-8a19-4643-9b09-43b488d4821a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "db99866f-e25c-42e2-853e-ef731cb1578a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "id": "int_15",
        "name": "Chinese medicine/herbals",
        "type": {
          "id": "544c5228-6948-40fe-91b4-34cb545fb017",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "17f3c752-6326-4f27-8e30-31a8f1153bd8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Veliparib",
        "administrableDoseForm": {
          "id": "acb745d8-4267-41bb-bed6-6e87b9509dd0",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "ef19bf1e-ec35-485a-8261-8e387c243eeb",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "0449c1f5-7b03-47e7-a3d8-82e44363db2b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_2",
        "name": "Carboplatin",
        "administrableDoseForm": {
          "id": "7ad76dd0-f840-4dc2-bee6-6f78d8386cef",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "9125ca1f-448a-42e7-8d15-1aa2470aa737",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8f1bf8a6-d1ac-402a-bfc9-5c8007fe4aa4",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "4dadd25f-9623-4610-9f3d-fad18cbc6089",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "b8853149-2aab-428b-92ad-cad468509621",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "d9be5ec3-50b5-4624-8880-8d0c20f013e4",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Veliparib/Placebo Combination Phase",
        "instanceType": "Administration",
        "dose": "120 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "id": "admin_2",
        "name": "Carboplatin",
        "instanceType": "Administration",
        "dose": "AUC 6",
        "doseFrequency": "once per cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "id": "admin_3",
        "name": "Paclitaxel",
        "instanceType": "Administration",
        "dose": "80 mg/m2",
        "doseFrequency": "weekly",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "id": "admin_4",
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "id": "admin_5",
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "instanceType": "Administration",
        "dose": "400 mg",
        "doseFrequency": "twice a day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Veliparib",
        "instanceType": "Substance",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "id": "sub_2",
        "name": "Carboplatin",
        "instanceType": "Substance",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "id": "sub_3",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 15,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Veliparib (ABT-888)",
        "role": "Investigational Product",
        "description": "PARP inhibitor for HER2-negative metastatic or locally advanced unresectable BRCA-associated breast cancer."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for veliparib."
      },
      {
        "name": "Carboplatin",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Paclitaxel",
        "role": "Background Therapy",
        "description": "Cytotoxic chemotherapy administered as reference therapy."
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Diphenhydramine",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "H2 antagonists",
        "role": "Concomitant Medication",
        "description": "Permitted for premedication to reduce hypersensitivity reactions."
      },
      {
        "name": "Palonosetron",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Dexamethasone",
        "role": "Concomitant Medication",
        "description": "Recommended antiemetic for moderately emetogenic therapy."
      },
      {
        "name": "Aprepitant",
        "role": "Concomitant Medication",
        "description": "Optional antiemetic."
      },
      {
        "name": "G-CSF",
        "role": "Concomitant Medication",
        "description": "Colony stimulating factor permitted for supportive care or to maintain dose intensity."
      },
      {
        "name": "Bisphosphonates",
        "role": "Concomitant Medication",
        "description": "Permitted for osteoporosis or bone metastases management; prohibited for anti-cancer effect."
      },
      {
        "name": "Denosumab",
        "role": "Concomitant Medication",
        "description": "Permitted for management of bone metastases."
      },
      {
        "name": "Anticancer hormonal therapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during the study; must be stopped 7 days before starting C1D-2."
      },
      {
        "name": "Chinese medicine/herbals",
        "role": "Concomitant Medication",
        "description": "Prohibited; requires a 14-day washout period."
      }
    ],
    "products": [
      {
        "name": "Veliparib",
        "doseForm": "Capsule",
        "strength": "Not specified",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Carboplatin",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Veliparib",
        "description": "PARP inhibitor (ABT-888)"
      },
      {
        "name": "Carboplatin",
        "description": "Platinum-based chemotherapeutic agent"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane-based chemotherapeutic agent"
      }
    ],
    "administrations": [
      {
        "name": "Veliparib/Placebo Combination Phase",
        "dose": "120 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days -2 through 5 of a 21-day cycle"
      },
      {
        "name": "Carboplatin",
        "dose": "AUC 6",
        "frequency": "once per cycle",
        "route": "Intravenous",
        "duration": "Day 1 of a 21-day cycle"
      },
      {
        "name": "Paclitaxel",
        "dose": "80 mg/m2",
        "frequency": "weekly",
        "route": "Intravenous",
        "duration": "Days 1, 8, and 15 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Starting)",
        "dose": "300 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle"
      },
      {
        "name": "Veliparib/Placebo Single-Agent Phase (Escalated)",
        "dose": "400 mg",
        "frequency": "twice a day",
        "route": "Oral",
        "duration": "Days 1 through 21 of a 21-day cycle (if 300 mg tolerated for 2 weeks)"
      }
    ],
    "devices": []
  }
}